S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
LON:CLLN

Carillion (CLLN) Share Price, News & Analysis

GBX 14.20
-0.07 (-0.49%)
(As of 12/19/2019)
Today's Range
12.50
20.70
50-Day Range
14.20
14.20
52-Week Range
12.50
20.70
Volume
15,330 shs
Average Volume
15,330 shs
Market Capitalization
£61.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CLLN stock logo

About Carillion Stock (LON:CLLN)

Carillion plc is an integrated support services company. The Company operates through four business segments: Support services, Public Private Partnership projects, Middle East construction services and Construction services (excluding the Middle East). The Support Services segment includes its facilities management, facilities services, energy services, rail services, road maintenance services, utilities services, remote site accommodation services and consultancy businesses in the United Kingdom, Canada and the Middle East. The Public Private Partnership projects segment invests in Public Private Partnership projects in the United Kingdom and Canada. The Middle East construction services segment includes its building and civil engineering activities in the Middle East and North Africa. The Construction services segment includes its the United Kingdom building, civil engineering and developments businesses, together with those of its construction activities in Canada.

CLLN Stock Price History

CLLN Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Carillion plc (CLLN.L)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
See More Headlines
Receive CLLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carillion and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
£61.10 million
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Keith R. Cochrane CBE (Age 52)
    Executive Director
  • Emma Mercer
    Chief Financial Officer
  • Andy Jones
    Chief Operating Officer
  • Richard F. Tapp
    Secretary
  • Philip N. Green CBE (Age 63)
    Non-Executive Independent Chairman of the Board
  • Alan C. Lovell (Age 61)
    Non-Executive Director
  • Justin Richard Read (Age 56)
    Non-Executive Director
  • Alison Horner (Age 50)
    Independent Non-Executive Director
  • Sally Morgan (Age 57)
    Senior Independent Non-Executive Director

CLLN Stock Analysis - Frequently Asked Questions

How have CLLN shares performed in 2024?

Carillion's stock was trading at GBX 14.20 at the beginning of 2024. Since then, CLLN stock has increased by 0.0% and is now trading at GBX 14.20.
View the best growth stocks for 2024 here
.

Is Carillion a good dividend stock?

Carillion (LON:CLLN) pays an annual dividend of GBX 0.18 per share and currently has a dividend yield of 0.00%.
Read our dividend analysis for CLLN.

What other stocks do shareholders of Carillion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Carillion investors own include Petra Diamonds (PDL), CRH (CRH), Carclo (CAR), Lloyds Banking Group (LLOY), Carillion (CIOIF), HSBC (HSBC), Lloyds Banking Group (LYG), Wentworth Resources (WRL), Balfour Beatty (BBY) and Babcock International Group (BAB).

How do I buy shares of Carillion?

Shares of CLLN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:CLLN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners